Genexine, Inc. (KOSDAQ:095700)
South Korea · Delayed Price · Currency is KRW 2,990.00
-20.00 (-0.66%)
Jun 10, 2026, 3:30 PM KST
Genexine Market Cap
Genexine has a market cap or net worth of 136.89 billion as of June 10, 2026. Its market cap has decreased by -33.48% in one year.
Market Cap
136.89B
Enterprise Value
n/a
Revenue
5.81B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,990.00
Market Cap Chart
Since September 15, 2009, Genexine's market cap has increased from 109.02B to 136.89B, an increase of 25.57%. That is a compound annual growth rate of 1.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 136.89B | -35.75% |
| Dec 30, 2025 | 213.07B | -12.27% |
| Dec 30, 2024 | 242.86B | -40.82% |
| Dec 28, 2023 | 410.35B | -12.73% |
| Dec 29, 2022 | 470.21B | -67.78% |
| Dec 30, 2021 | 1.46T | -52.47% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Helixmith | 212.28B |
| EASY BIO,Inc. | 196.18B |
| Bioneer | 188.42B |
| JETEMA, | 178.98B |
| Macrogen | 124.57B |
| Vaxcell-Bio Therapeutics | 119.08B |
| MedPacto | 107.11B |
| Amicogen | 92.65B |